STE · News · 20260804N

Guidance / Outlook

STERIS plc · 2026-08-04 · Importance 44 · Surprise 24

STERIS reaffirmed its fiscal 2027 revenue and adjusted earnings-per-share guidance after reporting first-quarter results. Management expects the North Carolina chemistry investment to generate a significant return on invested capital within three to five years. Capital expenditure projections were increased to reflect the $600 million facility, while free cash flow expectations were slightly lowered because of the investment and restructuring program. Analysts also expect a recovery in Applied Sterilization Technologies services during the second half of fiscal 2027.

Key facts